4.6 Review

Functional evaluation in inherited retinal disease

Journal

BRITISH JOURNAL OF OPHTHALMOLOGY
Volume 106, Issue 11, Pages 1479-1487

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/bjophthalmol-2021-319994

Keywords

genetics; retina; diagnostic tests; investigation; clinical trial

Categories

Funding

  1. Wellcome Trust [099173/Z/12/Z]
  2. National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust
  3. UCL Institute of Ophthalmology
  4. Moorfields Eye Charity
  5. Retina UK
  6. Wellcome Trust [099173/Z/12/Z] Funding Source: Wellcome Trust

Ask authors/readers for more resources

Functional assessments play a crucial role in the clinical evaluation of patients with inherited retinal diseases, with a significant impact on various intervention approaches. These assessments help diagnose and monitor specific genotypes, but also come with limitations and challenges, requiring exploration of more effective analytical methods.
Functional assessments are a fundamental part of the clinical evaluation of patients with inherited retinal diseases (IRDs). Their importance and impact have become increasingly notable, given the significant breadth and number of clinical trials and studies investigating multiple avenues of intervention across a wide range of IRDs, including gene, pharmacological and cellular therapies. Moreover, the fact that many clinical trials are reporting improvements in vision, rather than the previously anticipated structural stability/slowing of degeneration, makes functional evaluation of primary relevance. In this review, we will describe a range of methods employed to characterise retinal function and functional vision, beginning with tests variably included in the clinic, such as visual acuity, electrophysiological assessment and colour discrimination, and then discussing assessments often reserved for clinical trials/research studies such as photoaversion testing, full-field static perimetry and microperimetry, and vision-guided mobility testing; addressing perimetry in greatest detail, given it is commonly a primary outcome metric. We will focus on how these tests can help diagnose and monitor particular genotypes, also noting their limitations/challenges and exploring analytical methodologies for better exploiting functional measurements, as well as how they facilitate patient inclusion and stratification in clinical trials and serve as outcome measures.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available